Plasma proteomic associations with genetics and health in the UK ...
Oct 2, 2023 · To fulfil these aims, we formed the UK Biobank Pharma Proteomics Project (UKB-PPP)—a precompetitive consortium of 13 biopharmaceutical companies funding the generation of multiplex,...
UK Biobank Pharma Proteomics Project (UKB-PPP)
The UKB-PPP is a collaboration between the UK Biobank (UKB) and thirteen biopharmaceutical companies characterising the plasma proteomic profiles of 54,219 UKB participants.
UKB-PPP - Synapse
'UKB-PPP' (Synapse ID: syn51364943) is a project on Synapse. Synapse is a platform for supporting scientific collaborations centered around shared biomedical data sets.
Rare variant associations with plasma protein levels in the UK …
Oct 4, 2023 · The UKB Pharma Plasma Proteome (UKB-PPP) cohort comprises plasma samples from 54,219 individuals, including 46,595 randomly selected participants, 6,376 consortium-chosen individuals...
Plasma proteomic associations with genetics and health in the UK ...
We present comprehensive protein quantitative trait locus (pQTL) mapping of 2,923 proteins that identifies 14,287 primary genetic associations, of which 81% are previously undescribed, alongside ancestry-specific pQTL mapping in non-European individuals.
A pivotal moment for biomedical science — Olink®
As recently announced, the UK Biobank Pharma Proteomics Project (UKB-PPP) aims to use Olink® Explore HT to measure over 5,400 proteins in 600,000 samples from UKB participants.
Biobank Pharma Proteomics Project (UKB-PPP) for normalized protein expression (.NPX) data generated using the antibody-based Olink Explore™ Proximity Extension Assay (PEA) in blood plasma samples derived from approximately 54,000 UK Biobank participants.
Thermo Fisher Scientific’s Olink Platform Selected for World’s …
Jan 10, 2025 · Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the UK Biobank Pharma Proteomics Project (UKB-PPP) has selected its Olink ® Explore Platform to...
Thermo Fisher Scientific Inc. - Thermo Fisher Scientific’s Olink ...
Jan 9, 2025 · WALTHAM, Mass.-- (BUSINESS WIRE)-- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the UK Biobank Pharma Proteomics Project (UKB-PPP) has selected its Olink ® Explore Platform to support the world’s largest human proteomics study of its kind.
Publication 9421 - University of Oxford
Large-scale proteomic profiling to facilitate genetics-guided drug discovery and precision medicine: The UK Biobank - Pharma Proteomics Project (UKB-PPP)
- Some results have been hidden because they may be inaccessible to you.Show inaccessible results